Folgen
Kerstin Hermelink
Kerstin Hermelink
Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich
Bestätigte E-Mail-Adresse bei med.uni-muenchen.de
Titel
Zitiert von
Zitiert von
Jahr
Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study
K Hermelink, M Untch, MP Lux, R Kreienberg, T Beck, I Bauerfeind, ...
Cancer 109 (9), 1905-1913, 2007
4352007
Two different sides of ‘chemobrain’: determinants and nondeterminants of self‐perceived cognitive dysfunction in a prospective, randomized, multicenter study
K Hermelink, H Küchenhoff, M Untch, I Bauerfeind, MP Lux, M Bühner, ...
Psycho‐oncology 19 (12), 1321-1328, 2010
1782010
Short‐term effects of treatment‐induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study
K Hermelink, V Henschel, M Untch, I Bauerfeind, MP Lux, K Munzel
Cancer 113 (9), 2431-2439, 2008
1112008
Elucidating pretreatment cognitive impairment in breast cancer patients: the impact of cancer-related post-traumatic stress
K Hermelink, V Voigt, J Kaste, F Neufeld, R Wuerstlein, M Bühner, ...
Journal of the National Cancer Institute 107 (7), djv099, 2015
1052015
Chemotherapy and cognitive function in breast cancer patients: the so-called chemo brain
K Hermelink
Journal of the National Cancer Institute Monographs 2015 (51), 67-69, 2015
1032015
Chemotherapy and post-traumatic stress in the causation of cognitive dysfunction in breast cancer patients
K Hermelink, M Bühner, P Sckopke, F Neufeld, J Kaste, V Voigt, K Münzel, ...
JNCI: Journal of the National Cancer Institute 109 (10), djx057, 2017
1022017
Clinically assessed posttraumatic stress in patients with breast cancer during the first year after diagnosis in the prospective, longitudinal, controlled COGNICARES study
V Voigt, F Neufeld, J Kaste, M Bühner, P Sckopke, R Wuerstlein, ...
Psycho‐Oncology 26 (1), 74-80, 2017
822017
Menopausal status in breast cancer patients with past chemotherapy determines long-term hypoactive sexual desire disorder
R Ochsenkühn, K Hermelink, AH Clayton, V von Schönfeldt, J Gallwas, ...
The Journal of Sexual Medicine 8 (5), 1486-1494, 2011
532011
International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the fifth symposium on primary systemic therapy in the …
V Amoroso, D Generali, T Buchholz, M Cristofanilli, R Pedersini, ...
Journal of the National Cancer Institute Monographs 2015 (51), 90-96, 2015
492015
Immunotherapy: new options in breast cancer treatment
M Untch, N Ditsch, K Hermelink
Informa Healthcare 3 (3), 403-408, 2003
482003
Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer
A Vattai, E Akyol, C Kuhn, S Hofmann, H Heidegger, F von Koch, ...
Journal of cancer research and clinical oncology 143, 1637-1647, 2017
402017
Factors associated with the decline of psychological support in hospitalized patients with cancer
T Pichler, A Dinkel, B Marten‐Mittag, K Hermelink, E Telzerow, ...
Psycho‐Oncology, 2019
332019
EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer
A Semmlinger, V von Schoenfeldt, V Wolf, A Meuter, TM Kolben, T Kolben, ...
BMC cancer 18, 1-9, 2018
262018
Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration
E Tremmel, S Hofmann, C Kuhn, H Heidegger, S Heublein, K Hermelink, ...
Breast Cancer: Targets and Therapy, 87-97, 2019
192019
TAAR1 induces a disturbed GSK3β phosphorylation in recurrent miscarriages through the ODC
S Stavrou, M Gratz, E Tremmel, C Kuhn, S Hofmann, H Heidegger, ...
Endocrine Connections 7 (2), 372-384, 2018
142018
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancer
A Vattai, V Cavailles, S Sixou, S Beyer, C Kuhn, M Peryanova, ...
Oncotarget 8 (62), 105356, 2017
142017
Dopamine synthesis and dopamine receptor expression are disturbed in recurrent miscarriages
MJ Gratz, S Stavrou, C Kuhn, S Hofmann, K Hermelink, H Heidegger, ...
Endocrine connections 7 (5), 727-738, 2018
102018
Distress in hospitalized cancer patients: Associations with personality traits, clinical and psychosocial characteristics
T Pichler, B Marten‐Mittag, K Hermelink, E Telzerow, T Frank, ...
Psycho‐Oncology 31 (5), 770-778, 2022
72022
Brief Distress Screening in Clinical Practice: Does it Help to Effectively Allocate Psycho-Oncological Support to Female Cancer Inpatients?
K Hermelink, H Höhn, S Hasmüller, J Gallwas, K Haertl, R Wuerstlein, ...
Breast Care 9 (2), 129-129, 2014
72014
Congruence and trajectories of device-measured and self-reported physical activity during therapy for early breast cancer
H Helbrich, M Braun, C Hanusch, G Mueller, H Falk, R Flondor, ...
Breast Cancer Research and Treatment 188, 351-359, 2021
52021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20